Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.

doi:10.1002/mds.21701

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society - 1 Jan 2008

Quattrone Aldo, Bagnato Antonio, Annesi Grazia, Novellino Fabiana, Morgante Letterio, Savettieri Giovanni, Zappia Mario, Tarantino Patrizia, Candiano Innocenza Claudia Cirò, Annesi Ferdinanda, Civitelli Donatella, Rocca Francesca Emanuela, D'Amelio Marco, Nicoletti Giuseppe, Morelli Maurizio, Petrone Alfredo, Loizzo Piercostanzo, Condino Francesca

Abstract excerpt

Myocardial (123)Metaiodobenzylguanidine (MIBG) enables the assessment of postganglionic sympathetic cardiac innervation. MIBG uptake is decreased in nearly all patients with Parkinson's disease (PD). Our objective was to evaluate MIBG uptake in patients with genetic PD. We investigated MIBG uptake in 14 patients with PD associated with mutations in different genes (Parkin, DJ-1, PINK1, and leucine-rich repeat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Movement Disorders

Share to Myocardium

Share to Oncogene Proteins

Share to Parkinsonian Disorders

Share to Protein Deglycase DJ-1

Share to Radiopharmaceuticals

Share to Tomography, Emission-Computed, Single-Photon

Source

Open in PubMed

Identifiers

PMID: 17975812
DOI: 10.1002/mds.21701

Genes

PINK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.PMID 17975812Read ↗

Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.Semantic proximity Read ↗

Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease.Semantic proximity Read ↗

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.Semantic proximity Read ↗

Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease.Semantic proximity Read ↗

Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation.Semantic proximity Read ↗

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.Semantic proximity Read ↗

Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism.Semantic proximity Read ↗

123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.Semantic proximity Read ↗

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.Semantic proximity Read ↗

Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.Semantic proximity Read ↗

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.Semantic proximity Read ↗

Abnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.